AAAAAA

   
Results: 1-20 |
Results: 20

Authors: BUJDAKOVA H LAUSOVA A JANKOVICOVA S PRODINGER WM KALLOVA J MILOSOVIC P KETTNER M
Citation: H. Bujdakova et al., STUDY OF BETA-LACTAM RESISTANCE IN CEFTAZIDIME-RESISTANT CLINICAL ISOLATES OF ENTEROBACTERIACEAE, International journal of antimicrobial agents, 10(2), 1998, pp. 135-141

Authors: PRODINGER WM HELLWAGE J SPRUTH M DIERICH MP ZIPFEL PF
Citation: Wm. Prodinger et al., THE C-TERMINUS OF FACTOR-H - MONOCLONAL-ANTIBODIES INHIBIT HEPARIN-BINDING AND IDENTIFY EPITOPES COMMON TO FACTOR-H AND FACTOR H-RELATED PROTEINS, Biochemical journal, 331, 1998, pp. 41-47

Authors: PRODINGER WM SCHWENDINGER MG SCHOCH J KOCHLE M LARCHER C DIERICH MP
Citation: Wm. Prodinger et al., CHARACTERIZATION OF C3DG BINDING TO A RECESS FORMED BETWEEN SCR-1 ANDSCR-2 OF COMPLEMENT RECEPTOR-TYPE-2, Molecular immunology, 35(6-7), 1998, pp. 248-248

Authors: SCHWENDINGER MG DIERICH MP PRODINGER WM
Citation: Mg. Schwendinger et al., CR-2-DEPENDENT ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT - EFFICACY OF THE CR-2-ASSOCIATED INITIAL C3-CONVERTASE IC3BBP, Molecular immunology, 35(6-7), 1998, pp. 249-249

Authors: PRODINGER WM HELLWAGE J SPRUTH M DIERICH MP ZIPFEL PF
Citation: Wm. Prodinger et al., THE C-TERMINUS OF FACTOR-H - MONOCLONAL-ANTIBODIES INHIBIT HEPARIN-BINDING AND IDENTIFY EPITOPES COMMON TO FACTOR-H AND FACTOR-H RELATED PROTEINS, Molecular immunology, 35(6-7), 1998, pp. 250-250

Authors: PRODINGER WM SCHWENDINGER MG SCHOCH J KOCHLE M LARCHER C DIERICH MP
Citation: Wm. Prodinger et al., CHARACTERIZATION OF C3DG BINDING TO A RECESS FORMED BETWEEN SHORT CONSENSUS REPEATS 1 AND 2 OF COMPLEMENT RECEPTOR-TYPE 2 (CR-2, CD21), The Journal of immunology (1950), 161(9), 1998, pp. 4604-4610

Authors: PRODINGER WM SCHOCH J SCHWENDINGER MG HELLWAGE J PARSON W ZIPFEL PF DIERICH MP
Citation: Wm. Prodinger et al., EXPRESSION IN INSECT CELLS OF THE FUNCTIONAL DOMAIN OF CD21 (COMPLEMENT RECEPTOR-TYPE-2) AS A TRUNCATED SOLUBLE MOLECULE USING A BACULOVIRUS VECTOR, Immunopharmacology, 38(1-2), 1997, pp. 141-148

Authors: SCHRATZBERGER P REINISCH N PRODINGER WM KAHLER CM SITTE BA BELLMANN R FISCHERCOLBRIE R WINKLER H WIEDERMANN CJ
Citation: P. Schratzberger et al., DIFFERENTIAL CHEMOTACTIC ACTIVITIES OF SENSORY NEUROPEPTIDES FOR HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, The Journal of immunology, 158(8), 1997, pp. 3895-3901

Authors: SCHWENDINGER MG SPRUTH M SCHOCH J DIERICH MP PRODINGER WM
Citation: Mg. Schwendinger et al., A NOVEL MECHANISM OF ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION ACCOUNTS FOR THE DEPOSITION OF C3 FRAGMENTS ON CR-2-EXPRESSING HOMOLOGOUS CELLS, The Journal of immunology, 158(11), 1997, pp. 5455-5463

Authors: PRODINGER WM FILLE M BAUERNFEIND A STEMPLINGER I AMANN S PFAUSLER B LASSFLORL C DIERICH MP
Citation: Wm. Prodinger et al., MOLECULAR EPIDEMIOLOGY OF KLEBSIELLA-PNEUMONIAE PRODUCING SHV-5 BETA-LACTAMASE - PARALLEL OUTBREAKS DUE TO MULTIPLE PLASMID TRANSFER, Journal of clinical microbiology, 34(3), 1996, pp. 564-568

Authors: PRODINGER WM LARCHER C SCHWENDINGER M DIERICH MP
Citation: Wm. Prodinger et al., LIGATION OF THE FUNCTIONAL DOMAIN OF COMPLEMENT RECEPTOR-TYPE-2 (CR-2, CD21) IS RELEVANT FOR COMPLEX-FORMATION IN T-CELL LINES, The Journal of immunology, 156(7), 1996, pp. 2580-2584

Authors: WURZNER R SOLDER BM PRODINGER WM DIERICH MP
Citation: R. Wurzner et al., COMPLEMENT C7 M N ALLOTYPING IN INFECTIOUS-DISEASES/, Experimental and clinical immunogenetics, 12(2), 1995, pp. 61-65

Authors: LARCHER C JULEN N PRODINGER WM TOTSCH M GURTLER L DIERICH MP
Citation: C. Larcher et al., REDUCED CD21(CR2) AND CD54 (ICAM-1) EXPRESSION IN MT2 CELLS WITH HIV-1 OR HIV-2 STRAINS, Immunology letters, 46(1-2), 1995, pp. 31-36

Authors: LARCHER C KEMPKES B KREMMER E PRODINGER WM PAWLITA M BORNKAMM GW DIERICH MP
Citation: C. Larcher et al., EXPRESSION OF EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 (EBNA2) INDUCES CD21 CR2 ON B-CELL AND T-CELL LINES AND SHEDDING OF SOLUBLE CD21/, European Journal of Immunology, 25(6), 1995, pp. 1713-1719

Authors: PRODINGER WM LARCHER C SOLDER BM GEISSLER D DIERICH MP
Citation: Wm. Prodinger et al., HEPATITIS-A IN WESTERN AUSTRIA - THE EPIDEMIOLOGIC SITUATION BEFORE THE INTRODUCTION OF ACTIVE IMMUNIZATION, Infection, 22(1), 1994, pp. 53-55

Authors: PRODINGER WM BONATTI H ALLERBERGER F WEWALKA G HARRISON TG AICHBERGER C DIERICH MP MARGREITER R TIEFENBRUNNER F
Citation: Wm. Prodinger et al., LEGIONELLA-PNEUMONIA IN TRANSPLANT RECIPIENTS - A CLUSTER OF CASES OF8 YEARS DURATION, The Journal of hospital infection, 26(3), 1994, pp. 191-202

Authors: MOST J LARCHER C VOGETSEDER W PRODINGER WM HUEMER HP EBENBICHLER CF DIERICH MP
Citation: J. Most et al., DOSE DEPENDENCE OF VACCINE ANTIGENS, Vaccine, 11(6), 1993, pp. 689-689

Authors: IMARHIAGBE D PRODINGER WM SCHMUTZHARD E
Citation: D. Imarhiagbe et al., AN INFECTIOUS ETIOLOGY OF BELLS-PALSY, Wiener Klinische Wochenschrift, 105(21), 1993, pp. 611-613

Authors: PUCHHAMMERSTOCKL E HEINZ FX PRODINGER WM KUNZ C
Citation: E. Puchhammerstockl et al., EARLY DIAGNOSIS OF PERINATALLY ACQUIRED HIV-INFECTION BY THE POLYMERASE CHAIN-REACTION, Wiener Klinische Wochenschrift, 105(15), 1993, pp. 429-432

Authors: HUEMER HP LARCHER C PRODINGER WM PETZER AL MITTERER M FALSER N
Citation: Hp. Huemer et al., DETERMINATION OF SOLUBLE CD21 AS A PARAMETER OF B-CELL ACTIVATION, Clinical and experimental immunology, 93(2), 1993, pp. 195-199
Risultati: 1-20 |